The Baltimore-based company is voluntarily recalling the antibiotic for being subpotent, according to the report.
The drug is manufactured by Novel Laboratories for Lupin.
More articles on pharmacy:
Hospital-owned drug company attracts 12 more health systems
How nurses are becoming integral to pharma marketing: 7 notes
4 tips for managing drug spend from Alameda Health System’s Dr. Yi-Chih Peng
